OmniAb OABI
NASDAQ OABI
$4.47 -0.28 (-5.89%)
As of: Sep 4, 2026 · 12:51 PM EDT

OmniAb (OABI) Debt Ratio (2021 - 2026)

OmniAb (OABI) posted quarterly Debt Ratio of 0.0 for Q1 2026, up 195.97% year-over-year from 0.0 in Q1 2025, and down 1.65% quarter-over-quarter from 0.0 in Q4 2025.

Analysis

OmniAb (OABI) Debt Ratio (2021 - 2026) Analysis & Trends

OmniAb (OABI) has reported Debt Ratio for 6 consecutive years, with 0.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Debt Ratio rose 195.97% year-over-year to 0.0; the TTM figure through Mar 2026 stood at 0.0 (up 195.97% YoY), while the FY2025 annual figure was 0.0, up 112.71% from the prior year.
  • Debt Ratio eased to 0.0 in Q1 2026 per OABI's latest filing, from 0.0 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.01 in Q4 2022 and bottomed at 0.0 in Q1 2022.
  • Historically, Debt Ratio has averaged 0.0 across 5 years, with a median of 0.0 in 2024.
  • Annual changes were most pronounced in 2023 — Debt Ratio jumped 3224.45% — and 2024, when it slumped 85.97%.
  • OmniAb's Debt Ratio stood at 0.01 in 2022, then plunged by 63.63% to 0.0 in 2023, then sank by 53.03% to 0.0 in 2024, then soared by 112.71% to 0.0 in 2025, then retreated by 1.65% to 0.0 in 2026.
  • Business Quant data shows OABI's Debt Ratio at 0.0 in Q1 2026, 0.0 in Q4 2025, and 0.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn 0.05
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn -
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn 0.05
5 Revolution Medicines 44.05 Bn 44.05 Bn - -
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn 0.12
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn -
8 Royalty Pharma 28.52 Bn 27.68 Bn - 0.47
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn 0.26
10 OmniAb 576.36 Mn 524.36 Mn 12.81 Mn 0.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.01
Mar 31, 2023 0.01
Dec 31, 2022 0.01
Sep 30, 2022 0.00
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Dec 31, 2021 0.01
Jun 30, 2021 0.00